ABO and Alzheimer disease: Because of the relevant neuropathogenic role played by Aβ oligomers (AβOs), the main neurotoxic species in AD [23] that is mostly determinant for glial activation and cognitive deficits [13, 24], we used immunostaining with the A11 anti-AβO antibody to assess if MSC-CS had modified their load.